Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Multiple Myeloma 22Leukemia, Myeloid, Acute 21Lymphoma, Non-Hodgkin 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma 9Hodgkin Disease 8Myelodysplastic Syndromes 7Neoplasms, Plasma Cell 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia, Lymphocytic, Chronic, B-Cell 6Leukemia 6Recurrence 3Pancreatic Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Gliosarcoma 3Glioblastoma 3Sezary Syndrome 2Myeloproliferative Disorders 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Hairy Cell 2Hematologic Neoplasms 2Glioma 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Sarcoma, Myeloid 1

Interventions

Temozolomide 5Cyclophosphamide 4Filgrastim 3Carboplatin 3Automobiles 3fludarabine 2etoposide phosphate 2Thiotepa 2Surgical Procedures, Operative 2Sirolimus 2Proton Therapy 2Magnetic Resonance Spectroscopy 2Irinotecan 2Granulocyte Colony-Stimulating Factor 2Gadolinium DTPA 2Etoposide 2Donepezil 2Celecoxib 2trametinib 1tozuleristide 1temsirolimus 1sonidegib 1ribociclib 1plerixafor 1omburtamab I-131 1gallium Ga 68 dotatate 1gadobutrol 1gadobenic acid 1Yoga 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pinealoma × plerixafor × Clear all
NCT01977677 2018-10-23

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma

Stanford University

Phase 1/2 Completed
30 enrolled 11 charts
CNSSarcoma

Glioblastoma, Glioma, Medulloblastoma, Pinealoma, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡